Tag Archives: new approvals

Sanofi’s Sarclisa Receives Approval in China for Newly Diagnosed Multiple Myeloma Treatment

(IN BRIEF) Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients who are ineligible for autologous stem cell transplant. The approval is based on positive results from … Read the full press release